Search research articles
Contact Us
Filters
Showing results (291-300 of 350) with videos related to
Page
of 35
Sort By:
Annals of Internal Medicine
|
December 8, 2015
Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study
Isabelle Cleynen, Wouter Van Moerkercke, Thomas Billiet, et al.
Journal of Crohn'S & Colitis
|
August 16, 2023
Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations
Stefan Schreiber, Silvio Danese, Axel Dignass, et al.
Journal of Crohn'S & Colitis
|
June 27, 2025
ECCO Topical Review on Pouch Disorders
Maia Kayal, Gabriele Bislenghi, Michel Adamina, et al.
Scientific Reports
|
February 23, 2026
Hydrogen sulfide rescues IFNγ/TNFα-induced intestinal epithelial barrier dysfunction by enhancing oxidative phosphorylation
Janaíne Prata de Oliveira, Matthias van Sligtenhorst, Cansu Akkaya, et al.
BMC Gastroenterology
|
March 28, 2024
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Alimentary Pharmacology & Therapeutics
|
July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
Stefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Inflammatory Bowel Diseases
|
January 31, 2022
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial
Julian Panés, Gerd Bouma, Marc Ferrante, et al.
The American Journal of Gastroenterology
|
September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial
Silvio Danese, Marc Ferrante, Brian G Feagan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2025
Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study
Vipul Jairath, Geert D'Haens, Bruce E Sands, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 11, 2022
Severity of the S1251N allele in cystic fibrosis is affected by the presence of the F508C variant in cis
Senne Cuyx, Sofia S Ramalho, Isabelle Callebaut, et al.
Page
of 35
Search research articles
Search
Showing results (291-300 of 350) with videos related to
Sort By:
Page
of 35
Annals of Internal Medicine
|
December 8, 2015
Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study
Isabelle Cleynen, Wouter Van Moerkercke, Thomas Billiet, et al.
Journal of Crohn'S & Colitis
|
August 16, 2023
Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations
Stefan Schreiber, Silvio Danese, Axel Dignass, et al.
Journal of Crohn'S & Colitis
|
June 27, 2025
ECCO Topical Review on Pouch Disorders
Maia Kayal, Gabriele Bislenghi, Michel Adamina, et al.
Scientific Reports
|
February 23, 2026
Hydrogen sulfide rescues IFNγ/TNFα-induced intestinal epithelial barrier dysfunction by enhancing oxidative phosphorylation
Janaíne Prata de Oliveira, Matthias van Sligtenhorst, Cansu Akkaya, et al.
BMC Gastroenterology
|
March 28, 2024
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Alimentary Pharmacology & Therapeutics
|
July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
Stefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Inflammatory Bowel Diseases
|
January 31, 2022
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial
Julian Panés, Gerd Bouma, Marc Ferrante, et al.
The American Journal of Gastroenterology
|
September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial
Silvio Danese, Marc Ferrante, Brian G Feagan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2025
Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study
Vipul Jairath, Geert D'Haens, Bruce E Sands, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 11, 2022
Severity of the S1251N allele in cystic fibrosis is affected by the presence of the F508C variant in cis
Senne Cuyx, Sofia S Ramalho, Isabelle Callebaut, et al.
Page
of 35